II
ImmunoBiotics, Inc. Stock: price and insider trades · United States
ImmunoBiotics, Inc.: what insiders have been doing
We have very little insider data for ImmunoBiotics, Inc. so far: the most recent filing dates from 25 May 2010. With so few records, no pattern can be drawn yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 25 May 2010
Declarations2 total
- 2,000,000 shares0Common Stock, par value $.001SEC:0001140361-10-023072:0
- 2,000,000 shares0Common Stock, par value $.001SEC:0001140361-10-023074:0
2 of 2 declarations
About ImmunoBiotics, Inc.
ImmunoBiotics, Inc. is a company focused on developing biopharmaceutical solutions. It specializes in the research and commercialization of innovative immunological treatments.
